News | August 25, 2008

MRI-Guided Focused Ultrasound Conference Targets Cancer, Stroke Treatments

August 25, 2008 - The Focused Ultrasound Surgery Foundation will host an international symposium dedicated to the current and future use of magnetic resonance guided focused ultrasound surgery (MRgFUS), a therapeutic technology for treating a variety of medical conditions including cancer, neurological disorders and uterine fibroids.

The MRgFUS 2008 International Symposium, to be held on Oct, 6-7 in Washington, D.C., will feature more than 75 clinicians, scientists and engineers from over 12 countries who are contributing to the rapid advancement of this field. The multidisciplinary program will span the latest research, current and future clinical applications and practical issues related to adoption including best practices, training, and reimbursement.

MRgFUS is the result of the integration of two technologies: high intensity focused ultrasound and magnetic resonance imaging. Focused ultrasound technology uses multiple intersecting beams of ultrasound energy focused with extreme precision on a target as small as 1mm in diameter. Each individual ultrasound beam passes through the tissue there is no effect, but where they intersect in the body, the focused energy creates a cumulative effect, enabling precise ablation of tissue, highly targeted drug delivery, or liquefaction of blood clots. Magnetic resonance imaging is used to visualize normal anatomy and abnormal structures within the body, to localize the tissue to be targeted, to guide and control the treatment interactively, and to evaluate the effectiveness of therapy.

MRgFUS is a minimally invasive surgery; a means for delivering drugs in high concentrations to the point where they are needed; and dissolving blood clots and restoring circulation. MRgFUS is already established for the treatment of uterine fibroids and holds the potential to noninvasively treat breast, prostate, liver and other benign and malignant tumors; to convert metastatic cancer from a lethal disease to a manageable, chronic disorder; to reverse the disabling and life threatening neurological deficits from stroke; to alleviate the symptoms of Parkinson's disease, epilepsy, and chronic pain; and to address the host of other disorders ranging from heart disease to diabetes.

MRgFUS can be performed on an outpatient basis, does not require general anesthesia or incisions, results in minimal discomfort and few complications, and allows rapid recovery.

For more information: www.fusfoundation.org

Related Content

Russian Team Developing New Technology to Significantly Reduce MRI Research Costs
News | Magnetic Resonance Imaging (MRI)| January 16, 2018
January 16, 2018 — Researchers from the NUST MISIS Engineering Center for Industrial Technologies in Russia have deve
Videos | Magnetic Resonance Imaging (MRI)| December 13, 2017
Emanuel Kanal, M.D., director of MRI services and professor of radiology and neuroradiology at the University of Pitt
GE Healthcare Launches Blanket-Like Air Technology MRI Coils
Technology | Magnetic Resonance Imaging (MRI)| December 13, 2017
GE Healthcare announced U.S. FDA 510(k) clearance of its new Air Technology, what it calls an industry-first suite of...
Toshiba Vantage Galan 3T XGO Edition MRI Features New Advanced Gradient
Technology | Magnetic Resonance Imaging (MRI)| December 11, 2017
Toshiba Medical, a Canon Group company, demonstrated the Vantage Galan 3T XGO Edition with the all-new Saturn X...
Toshiba Launches Vantage Elan Zen Edition MR for Enhanced Patient Comfort
Technology | Magnetic Resonance Imaging (MRI)| December 05, 2017
Toshiba Medical, a Canon Group company, introduced its newest magnetic resonance (MR) system, the Vantage Elan/Zen...
FDA Clears Siemens Magnetom Terra 7T MRI Device

The FDA has cleared the Siemens Magnetom Terra as the first 7T MRI system in the U.S. to gain regulatory approval.

Technology | Magnetic Resonance Imaging (MRI)| October 12, 2017
The U.S. Food and Drug Administration (FDA) cleared the first 7 Tesla (7T) magnetic resonance imaging (MRI) device,...
MR Solutions Showcases Multimodality MRI Solutions on Two Continents
News | Magnetic Resonance Imaging (MRI)| October 11, 2017
MR Solutions took their cryogen-free preclinical multimodality magnetic resonance imaging (MRI) solutions on tour in...
Toshiba Showcases MRI Workflow Enhancements at RSNA 2017
News | Magnetic Resonance Imaging (MRI)| September 21, 2017
September 21, 2017 — Toshiba Medical will highlight its latest...
GE Healthcxare Signa Pioneer MAGIC six contrasts in one scan software by SyntheticMR.

The MRI software enables several different contrasts to be obtained from one scan, shortening scan times.

Feature | Magnetic Resonance Imaging (MRI)| August 31, 2017
August 31, 2017 — The U.S. Food and Drug Administration (FDA) has granted market clearance for SyntheticMR’s SyMRI.
ISMRM Issues Guidelines for MRI Gadolinium Contrast Agents
News | Magnetic Resonance Imaging (MRI)| August 15, 2017
The International Society for Magnetic Resonance in Medicine (ISMRM) has provided new guidance in the use of contrast...
Overlay Init